Local Radiotherapy for Residual Tumor Lesions During the First-line Treatment

NCT05205226 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 636

Last updated 2022-01-25

No results posted yet for this study

Summary

This study aimed to confirmed that local radiotherapy for residual lesions can significantly prolong the efficacy of chemotherapy combined with immunotherapy in the initial treatment of advanced non-small cell lung cancer.

Conditions

  • Non Small Cell Lung Cancer

Sponsors & Collaborators

  • Hunan Province Tumor Hospital

    lead OTHER

Principal Investigators

  • Yongchang C Zhang, MD · Hunan Cancer Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-02
Primary Completion
2021-06-05
Completion
2022-01-02

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05205226 on ClinicalTrials.gov